Scale genomics without compromising data integrity on icon96
4 Mar 2026
One of the biggest challenges in scaling genomics is maintaining data quality as throughput increases. As applications like single-cell analysis, spatial biology, MRD, cancer diagnostics, and microbiome research become more complex, traditional PCR and normalization workflows are struggling to keep up. In this SelectScience interview, Pranav Patel, Founder and CEO of n6 Tec, explains how the team is tackling this challenge with icon96™, the company's flagship amplification technology. By intelligently adjusting amplification based on sample quality and quantity, icon96 preserves data integrity, improves reproducibility, and eliminates the need for brute-force normalization.
This video was filmed at SLAS 2026.
About the company

n6 Tec., Inc
n6 is a pioneering genomics company rethinking how scientists prepare samples and generate data in the era of scaled sequencing. As the number of samples grows from thousands to millions, traditional workflows are too slow, too manual, and too variable. We're here to change that. Our flagship platform icon96™, powered by iconPCR™ technology, is designed to simplify to most complex part of the sequencing workflow — without compromising quality. With our proprietary AutoNorm™ technology, we help researchers move seamlessly from amplification to quantification to normalization in a single step. The result: cleaner data, faster decisions, and fewer barriers to discovery. At n6, we combine deep technical expertise with a collaborative, scientist-first approach. We're passionate about building tools that make genomics more accessible, scalable, and reliable — for every lab, everywhere.
